Fig. 2From: Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patientsDeoxy (in blue) and oxyhemoglobin (in red) concentrations as a function of the time for one migraine patient at T0Back to article page